Skip to content

MDLN · NASDAQ

Medline (MDLN) Stock Price & Fundamentals

$879.27−0.78%−$6.93End-of-day price as of Oct 9, 2026

Medline (MDLN) closed at $879.27 on Oct 9, 2026, down 0.78% from the previous close of $886.20.

Share price, past year

1Y +45.89%

52-week range $602.68 – $909.45. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$879.27
Sep 30, 2026$904.93
Aug 31, 2026$876.54
Jul 31, 2026$825.29
Jun 30, 2026$764.61
May 29, 2026$761.32
Apr 30, 2026$740.44
Mar 31, 2026$690.89
Feb 27, 2026$651.32
Jan 30, 2026$657.12
Dec 31, 2025$678.18
Nov 28, 2025$656.69
Oct 31, 2025$610.10

Key statistics

Market cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Net income (TTM)
—
Shares outstanding
—
Dividend yield
—
52-week range
$602.68 – $909.45

Financials

Medline reported revenue of $28.43B for fiscal 2025, up 11.47% from fiscal 2024.

Medline earned net income of $1.16B in fiscal 2025, a net margin of 4.1%.

Annual revenue

FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Medline annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$28.43B+11.5%$1.16B4.1%−$0.01$1.30B
FY2024ended Dec 31, 2024$25.51B+9.8%———$1.42B
FY2023ended Dec 31, 2023$23.23B————$1.41B
Medline quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 27, 2026$7.69B—$0.07
Q1 FY2026ended Mar 28, 2026$7.35B—$0.16
Q2 FY2025ended Jun 28, 2025$6.89B$329.00M—
Q1 FY2025ended Mar 29, 2025$6.64B$319.00M—

Company profile

Name
Medline Inc.
Ticker
MDLN
Exchange
NASDAQ
Industry (SEC SIC)
Surgical & Medical Instruments & Apparatus
Headquarters
3 Lakes Drive, Northfield, IL 60093
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0002046386

Recent SEC filings

Frequently asked questions

What is Medline's stock price?

Medline (MDLN) closed at $879.27 on Oct 9, 2026, down 0.78% from the previous close of $886.20.

How much revenue does Medline make?

Medline reported revenue of $28.43B for fiscal 2025, up 11.47% from fiscal 2024.

Sources and methodology

Fundamentals come from Medline Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures